TICKVALE
>⌘K
NYSE · CIK 0000010456 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

BAXTER INTERNATIONAL INC.

BAX chart by TradingView
P/E P/B 1.8xP/SALES 1.0xEV/EBITDA FCF YIELD

PRICE HISTORY

LIVE · NYSE
BAX chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$11.2B
EBITDA
$0.7B
FREE CASH FLOW
$0.3B
EPS
$-1.87
GROSS MARGIN
30.05%
ROIC
-7.04%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

+3282%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.9x180.0x

P / SALES (TTM)

1.0x
-63%
LATEST · Q2 FY26
1.0xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.8x4.1x

P / BOOK

1.8x
-41%
LATEST · Q2 FY26
1.8xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
1.4x6.0x

EV / EBITDA (TTM)

+42%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
18.0x26.3x

EV / REVENUE (TTM)

-59%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
1.5x4.8x

FCF YIELD (TTM)

+3.2pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.36%6.58%

DIVIDEND YIELD (TTM)

0.94%
-0.1pp
LATEST · Q2 FY26
0.94%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.91%3.57%

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$3.0B
+16%
LATEST · Q2 FY26
3.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

$0.5B
+17%
LATEST · Q2 FY26
0.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$0.1B
-3%
LATEST · Q2 FY26
0.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$0.24
+3%
LATEST · Q2 FY26
0.24Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

5.34%
+2.5pp
LATEST · Q2 FY26
5.34%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-163.42%408.87%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

+96.8pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-58.62%111.09%

RETURN ON CAPITAL

-16.9pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-11.63%13.85%

RETURN ON EQUITY (TTM)

-17.13%
-73.9pp
LATEST · Q2 FY26
-17.13%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-51.23%59.89%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN34.86%
OPERATING MARGIN7.33%
NET MARGIN4.26%
FCF MARGIN
152.0988.4224.74-38.93-102.60GROSSOPERNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

+65%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.0B
+10%
LATEST · Q2 FY26
0.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

-142%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

0.52B
-6%
LATEST · Q2 FY26
0.52BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

$0.01
-92%
LATEST · Q2 FY26
0.01Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$2.1B
-17%
LATEST · Q2 FY26
2.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

+51%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

+449%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.6x14.0x

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 106.96%INSIDERS 0.34%OTHER / RETAIL 0.00%955 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.15.36%79.4M$2.19B-6.3%
Pzena Investment Management LLC12.48%64.5M$1.78B-7.9%
Dodge & Cox Inc.11.07%57.3M$1.58B+0.4%
FMR, LLC8.95%46.3M$1.27B+32.9%
Vanguard Capital Management LLC6.48%33.5M$923.1MNEW
Vanguard Portfolio Management LLC4.64%24.0M$661.0MNEW
State Street Corporation3.86%20.0M$550.4M-11.4%
Greenhaven Associates, Inc.2.76%14.3M$393.6M-0.2%
Geode Capital Management, LLC2.66%13.8M$379.2M+1.9%
Invesco Ltd.2.54%13.1M$361.5M+10.6%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.